Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients (RACHEL)

AstraZeneca

Status: Completed

Conditions: Dyslipidemias

Study type: Observational

Funder types: Industry

Identifiers

NCT00931320

NIS-CKR-DUM-2009/3

Details and patient eligibility

About

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia
• Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months
• Subjects who have records of both LDL-C and HDL-C before & after statin treatment (at least four weeks after statin taking)

Exclusion criteria

• Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Trial design

3,000 participants in 1 patient group

3000 patients

Description:

Who have at least made 1 visit to the outpatient clinic within previous 6 months .